Number of the records: 1  

Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial

  1. 1.
    SYSNO ASEP0506294
    Document TypeA - Abstract
    R&D Document TypeThe record was not marked in the RIV
    R&D Document TypeNení vybrán druh dokumentu
    TitleDendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial
    Author(s) Havel, L. (CZ)
    Zemanová, M. (CZ)
    Pešek, M. (CZ)
    Kolek, V. (CZ)
    Spíšek, R. (CZ)
    Bartůňková, J. (CZ)
    Pecen, Ladislav (UIVT-O) RID, SAI, ORCID
    Krasnopolskaya, I. (CZ)
    Černovská, M. (CZ)
    Source TitleJournal of Clinical Oncology - ISSN 0732-183X
    Roč. 36, 15 suppl (2018), s. 9051-9051
    Languageeng - English
    DOI10.1200/JCO.2018.36.15_suppl.9051
    WorkplaceInstitute of Computer Science
    ContactTereza Šírová, sirova@cs.cas.cz, Tel.: 266 053 800
    Year of Publishing2020
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.